Cargando…
Comparison of cell-based assays to quantify treatment effects of anticancer drugs identifies a new application for Bodipy-L-cystine to measure apoptosis
Cell-based assays that measure anticancer drug effects are essential for evaluating chemotherapeutic agents. Many assays targeting various cellular mechanisms are available, leading to inconsistent results when using different techniques. We critically compared six common assays, as well as a new as...
Autores principales: | Kumar, Nita, Afjei, Rayhaneh, Massoud, Tarik F., Paulmurugan, Ramasamy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218539/ https://www.ncbi.nlm.nih.gov/pubmed/30397244 http://dx.doi.org/10.1038/s41598-018-34696-x |
Ejemplares similares
-
A protein folding molecular imaging biosensor monitors the effects of drugs that restore mutant p53 structure and its downstream function in glioblastoma cells
por: Paulmurugan, Ramasamy, et al.
Publicado: (2018) -
Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model
por: Malhotra, Meenakshi, et al.
Publicado: (2018) -
A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations
por: Afjei, Rayhaneh, et al.
Publicado: (2022) -
A rationally identified panel of microRNAs targets multiple oncogenic pathways to enhance chemotherapeutic effects in glioblastoma models
por: Sadeghipour, Negar, et al.
Publicado: (2022) -
A molecularly engineered split reporter for imaging protein-protein interactions with positron emission tomography
por: Massoud, Tarik F., et al.
Publicado: (2010)